Gobir, AishaAriyibi, Solomon OIbraheem, Rasheedat MJohnson, Abdul-Wahab BRAbdulkadir, Mohammed BKatibi, Oludolapo SAdeoye, Peter OUdoh, E.Ailesanmi, OmotoyosiFolaranmi, Olalekan.O2023-01-092023-01-092022-06Gobir, A.A., Ariyibi, S.O., Ibraheem, R.M., Johnson, A.R., Abdulkadir, M.B., Katibi, O.S, Adeoye, P.O., Udoh, E.A, Ilesanmi, O.N., & Folaranmi, O.O. (2022): Disseminated tuberculosis in a Nigerian adolescent with Linear IgA Bullous Dermatosis: A case report and review of the literature. West African Journal of Medicine, 39(6), 646-650.0189 - 160Xhttps://uilspace.unilorin.edu.ng/handle/20.500.12484/8216Linear IgA bullous dermatosis (LABD) is an auto-immune disease affecting young children and adults, characterized by the linear deposition of IgA at the basement membrane zone with resultant complement activation and a cascade of immune reactions. There is a loss of adhesion at the dermo-epidermal junction and subsequent blister formation. It is a rare disease that has a good prognosis with adequate therapy. However, the underlying depressed immunity associated with the disease may expose them to such infections as tuberculosis. We report the case of an 11-years-old Nigerian female adolescent with LABD, diagnosed at the age of four years but defaulted on fol low-up, who developed disseminated tuberculosis (pulmonary, lymph nodes, abdominal and pericardial effusion) seven years after the appearance of the initial blistering skin lesions. She commenced anti-tuberculosis drugs, steroids, and a tube pericardiostomy for the pericardial effusion. Dapsone was initiated for the LABD during the continuation phase of anti-tuberculosis therapy, with subsequent disappearance of the skin rash within two weeks. WAJM 2022; 39(6): 646– 650.enArticle